Compugen Ltd
Clinical trials sponsored by Compugen Ltd, explained in plain language.
-
New cancer drug enters first human safety trial
Disease control Recruiting nowThis is the first study in people to test the safety and find the right dose of a new drug called COM503. It will be given alone and in combination with another cancer drug to 200 adults with advanced solid tumors that have stopped responding to standard treatments. The main goal…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for ovarian cancer patients: experimental antibody aims to keep cancer at bay
Disease control Recruiting nowThis trial is testing whether an experimental antibody called COM701 can help control ovarian cancer that has returned after previous treatment. The study will involve 60 participants with relapsed platinum-sensitive ovarian cancer who will receive either COM701 or a placebo thro…
Phase: PHASE1, PHASE2 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC